The Effects of Recovery Compression Boots on Blood Lactate Levels, Functional Movement, and Joint Ange of Motion in Collegiate Athletes.

May 1, 2026 updated by: Kendra Nelson, University of Redlands

The Effects of Intermittent Pneumatic Compression Boots on Blood Lactate, Neuromuscular Function, and Range of Motion on Recovery Within Collegiate Athletes.

This study aims to evaluate the use of intermittent compression boots (IPC) on post exercise recovery in collegiate athletes. Blood lactate will be analyzed (use of a finger prick) as a marker of physiological recovery. We will also analyze pre- and post-ankle range of motion using a handheld VALD DynaMo device to assess joint recovery and vertical jump performance using VALD ForceDecks to measure muscle readiness. These tests are widely used in sports science research but have not been measured collectively as a means to assess performance.

Study Overview

Status

Active, not recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

38

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • California
      • Redlands, California, United States, 92373
        • University of Redlands

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • NCAA athlete at the University of Redlands
  • 18-23 years of age; must be able to perform a squat jump
  • must be okay with finger-prick blood sample collection
  • must be between 5'4" and 6'2" in height

Exclusion Criteria:

  • No leg injury in the past 6 months
  • No leg surgery in the past 5 years
  • no history of DVT

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control Group
Experimental: Compression Boots
Normatec Intermittent Compression Boots
Device: Compression Boots
Normatec Intermittent Compression Boots

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Force Production
Time Frame: 1 hour
Countermovement Jump. A higher force production for the concentric portion of a CMJ is the desired outcome post intervention.
1 hour

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Lactate Levels
Time Frame: 1 hour
Blood Lactate Levels measured in mmol/L. A lower value during and after intervention is the desired result.
1 hour

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Range of Motion
Time Frame: 1 hour
Ankle Dorsiflexion Range of Motion. Increased ankle ROM is the desired effect.
1 hour

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University of Redlands

Investigators

  • Principal Investigator: kendra nelson, DPT, University of Redlands

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2026

Primary Completion (Estimated)

June 1, 2028

Study Completion (Estimated)

June 1, 2028

Study Registration Dates

First Submitted

January 7, 2026

First Submitted That Met QC Criteria

May 1, 2026

First Posted (Actual)

May 7, 2026

Study Record Updates

Last Update Posted (Actual)

May 7, 2026

Last Update Submitted That Met QC Criteria

May 1, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 2025-042

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy Participants

Clinical Trials on Compression Boots

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Lebanon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe